These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24128019)

  • 21. Sugammadex can be part of the solution. Let's not make it part of the problem!
    Vannucci A
    Minerva Anestesiol; 2013 Jun; 79(6):587-9. PubMed ID: 23254172
    [No Abstract]   [Full Text] [Related]  

  • 22. Sugammadex: cyclodextrins, development of selective binding agents, pharmacology, clinical development, and future directions.
    Akha AS; Rosa J; Jahr JS; Li A; Kiai K
    Anesthesiol Clin; 2010 Dec; 28(4):691-708. PubMed ID: 21074746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sugammadex: an opportunity to change the practice of anesthesiology?
    Miller RD
    Anesth Analg; 2007 Mar; 104(3):477-8. PubMed ID: 17312188
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sugammadex use experience in pediatric oncology].
    Matinyan NV; Saltanov AI; Mareeva AA
    Anesteziol Reanimatol; 2013; (1):34-7. PubMed ID: 23808251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anesthetic management of a patient with Brugada syndrome - the use of sugammadex in major abdominal surgery.
    Conde R; Pereira M
    Braz J Anesthesiol; 2013; 63(1):159-60. PubMed ID: 23438810
    [No Abstract]   [Full Text] [Related]  

  • 26. Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown.
    Jones PM; Turkstra TP
    Anaesthesia; 2010 Jan; 65(1):89-90; author reply 90. PubMed ID: 20121783
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report.
    Kawano T; Tamura T; Hamaguchi M; Yatabe T; Yamashita K; Yokoyama M
    J Clin Anesth; 2012 Feb; 24(1):62-4. PubMed ID: 22154092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery times after sugammadex: is the data flawed?
    Kopman AF
    Acta Anaesthesiol Scand; 2014 Apr; 58(4):496-7. PubMed ID: 24400790
    [No Abstract]   [Full Text] [Related]  

  • 30. Sugammadex as rescue therapy for residual neuromuscular blockade in the intensive care unit.
    Carron M; Baratto F; Pettenuzzo T; Ori C
    Can J Anaesth; 2016 Dec; 63(12):1384-1385. PubMed ID: 27646527
    [No Abstract]   [Full Text] [Related]  

  • 31. Case of anaphylaxis induced by rocuronium treated with sugammadex.
    Esteves LO
    Braz J Anesthesiol; 2013; 63(6):511. PubMed ID: 24565351
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecule of the month. Sugammadex sodium.
    Drug News Perspect; 2007 Nov; 20(9):591-2. PubMed ID: 18176664
    [No Abstract]   [Full Text] [Related]  

  • 33. Is the effect of sugammadex always rapid in onset?
    Van Gestel L; Cammu G
    Acta Anaesthesiol Belg; 2013; 64(2):41-7. PubMed ID: 24191525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing sugammadex and neostigmine reversal of neuromuscular blockade in laparoscopic surgery.
    Jain D; Gandhi K
    Anaesthesia; 2013 Mar; 68(3):306-7. PubMed ID: 23384266
    [No Abstract]   [Full Text] [Related]  

  • 35. Sugammadex to reverse neuromuscular blockade in a child with a past history of cardiac transplantation.
    Miller K; Hall B; Tobias JD
    Ann Card Anaesth; 2017; 20(3):376-378. PubMed ID: 28701612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sugammadex.
    Karalapillai D; Kaufman M; Weinberg L
    Crit Care Resusc; 2013 Mar; 15(1):57-62. PubMed ID: 23432503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sugammadex: A Review of Neuromuscular Blockade Reversal.
    Keating GM
    Drugs; 2016 Jul; 76(10):1041-52. PubMed ID: 27324403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of rocuronium-induced anaphylactic shock, improved by sugammadex].
    Badaoui R; Popov I; Dupont H
    Can J Anaesth; 2012 Sep; 59(9):909-10. PubMed ID: 22653841
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rocuronium used in rapid sequence intubation and reversal with sugammadex in a patient with myasthenia gravis].
    Illodo Miramontes G; Doniz Campos M; Filgueira Garrido P; Vázquez Martínez A
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):626-7. PubMed ID: 22263415
    [No Abstract]   [Full Text] [Related]  

  • 40. Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block.
    Hogg RM; Mirakhur RK
    Expert Rev Neurother; 2009 May; 9(5):599-608. PubMed ID: 19402771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.